Skip to Content

Oyster Point Pharma, Inc.

Merger

  • Date:
  • 11/7/2022
  • Company Name:
  • Oyster Point Pharma, Inc.
  • Stock Symbol:
  • OYST
  • Company Name - Buyer:
  • Viatris Inc.
  • Stock Symbol - Buyer:
  • VTRS
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 11/7/2022

Case Finder

Locate any case using the tools below.

NEW YORK, November 7, 2022 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Oyster Point Pharma, Inc. (NASDAQ: OYST) (“Oyster”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Viatris Inc. (NASDAQ: VTRS) (“Viatris”).

On November 7, 2022, Oyster announced that it had entered into an agreement to be acquired by Viatris in a cash and CVR deal. Pursuant to the merger agreement, Viatris will commence a tender offer to purchase all outstanding shares of Oyster for $11.00 per share in cash at closing, plus a contingent value right (“CVR”) for a potential cash payment of up to $2.00 per share upon achievement of specified performance targets by Oyster for full year 2022. The deal is expected to close in the first quarter of 2023.

Bragar Eagel & Squire is concerned that Oyster’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Oyster’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Oyster Point Pharma. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: